Edition:
United Kingdom

BioXcel Therapeutics Inc (BTAI.OQ)

BTAI.OQ on NASDAQ Stock Exchange Capital Market

10.85USD
24 May 2019
Change (% chg)

$0.81 (+8.07%)
Prev Close
$10.04
Open
$9.89
Day's High
$10.97
Day's Low
$9.89
Volume
7,292
Avg. Vol
11,315
52-wk High
$14.28
52-wk Low
$2.41

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.460
FY 2018 Dec '18 0.00 -0.453
Sep '18 0.00 -0.312
Jun '18 0.00 -0.193
Mar '18 0.00 -0.374
FY 2017 Dec '17 0.00 -0.162
Sep '17 0.00 -0.059
Jun '17
Mar '17 0.00 -0.056
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 3 0.00 0.00 0.00 --
Quarter Ending Sep-19 3 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Year Ending Dec-20 4 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-19 4 -0.63 -0.56 -0.68 -0.45
Quarter Ending Sep-19 4 -0.78 -0.65 -0.96 -0.54
Year Ending Dec-19 4 -2.73 -2.39 -3.34 -2.35
Year Ending Dec-20 6 -3.43 -2.51 -5.09 -3.95
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 94.22 35.45
P/E High - Last 5 Yrs. -- 167.17 57.53
P/E Low - Last 5 Yrs. -- 52.50 28.17
Beta -- 1.21 0.95
Price to Sales (TTM) -- 40.27 9.26
Price to Book (MRQ) 5.25 11.70 4.16
Price to Tangible Book (MRQ) 5.25 16.91 4.94
Price to Cash Flow (TTM) -- 61.85 24.35
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.66
Dividend Yield - 5 Year Avg -- 0.06 0.72
Dividend 5 Year Growth Rate -- 0.95 3.10
Payout Ratio(TTM) -- 1.56 15.26

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 59.65 16.47
Sales (TTM) vs TTM 1 Yr. Ago -- 44.14 8.16
Sales - 5 Yr. Growth Rate -- 33.04 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.05 -8.63 19.77
EPS (TTM) vs TTM 1 Yr. Ago -133.38 -- --
EPS - 5 Yr. Growth Rate -- 22.34 7.24
Capital Spending - 5 Yr. Growth Rate -- 25.04 8.28

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.78 2.43
Current Ratio (MRQ) 5.59 3.85 3.37
LT Debt to Equity (MRQ) 0.00 7.67 14.38
Total Debt to Equity (MRQ) 0.00 20.72 19.78
Interest Coverage (TTM) -- 32.60 13.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 22.82 50.28
Gross Margin - 5 Yr. Avg. -- 59.31 51.33
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -15.27 15.88
Operating Margin (TTM) -- -115.55 -4.40
Operating Margin - 5 Yr. Avg. -- -31.08 11.12
Pre-Tax Margin (TTM) -- -115.56 -4.77
Pre-Tax Margin - 5 Yr. Avg. -- -33.62 16.00
Net Profit Margin (TTM) -- -121.20 -8.54
Net Profit Margin - 5 Yr. Avg. -- -38.59 11.23
Effective Tax Rate (TTM) -- 17.19 19.91
Effective Tax Rate - 5 Yr. Avg. -- 18.97 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 9,172,779 746,078,341
Net Income/Employee (TTM) -1,232,889 1,703,221 87,169,841
Receivable Turnover (TTM) -- 11.73 5.69
Inventory Turnover (TTM) -- 2.44 3.64
Asset Turnover (TTM) 0.00 0.33 0.79

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.92 6.23 9.46
Return on Assets - 5 Yr. Avg. -- 6.13 10.47
Return on Investment (TTM) -51.83 7.58 11.75
Return on Investment - 5 Yr. Avg. -- 8.01 13.33
Return on Equity (TTM) -52.54 8.15 16.50
Return on Equity - 5 Yr. Avg. -- 9.06 14.89
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -355.84 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for BioXcel Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.74 -0.19 55 7
13 Week 24.57 22.48 84 17
26 Week 92.34 80.59 94 8
52 Week -4.74 -7.75 65 16
YTD 160.10 131.04 95 6
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.16%
# of Holders: 24
Total Shares Held: 3,314,552
3 Mo. Net Change: 90,130
# New Positions: 9
# Closed Positions: 2
# Increased Positions: 15
# Reduced Positions: 7
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.